Focus and Scope
The Brazilian Journal of Pharmaceutical Sciences accepts for publication Original Papers applicable to the fields of Pharmaceutical Sciences; Reviews and Current Comment Articles, which are published under the Scientific Editor and Associate Editors invitation to recognized experts or when they are spontaneously submitted by the authors in the form of abstracts to have their importance evaluated. A critical view of the subject with insertions of results of previous works in the field in relation to the state of art must be included; Short Communications reporting new methods and previews of works on researches of outstanding importance in which originality justify a quick publication. A maximum of 2000 words excluding tables, figures and references is an acceptable limit. One table, one figure and ten references may be added, and Book Reviews of the latest editions of books, prepared by specialists invited by the Scientific Editor and Associate Editors. Thematic Supplements as well as those related to scientific meetings can be published under the Scientific Editor and/or Associate Editors agreement.
It is mandatory to include the approval of Ethics Committees for those works related to human and /or animal research.
Manuscripts that are not in agreement of the Instructions will be refused prior to peer review. They can be submitted by either Brazilian or foreign specialists and written in English. A manuscript is accepted with the understanding that the material has not been previously published, except in abstract form, and that it is not simultaneously under consideration by any other journal. All manuscripts submitted to Brazilian Journal of Pharmaceutical Sciences that follow the Instructions to authors are subject to peer review by two or more independent, anonymous referees chosen by the Scientific Editor. Additional opinions are sought by the Scientific Editor when there are substantial differences between reviewers. After being reviewed all manuscripts are forwarded to the Associate Editors and Scientific Editor for a final decision. Rejected manuscripts may be resubmitted for consideration without any reference to the previous submission as a new manuscript after being properly and significantly restructured. If revision is necessary, the authors are asked to resubmit the dated, revised manuscript incorporating the suggestions and recommendations of the referees within two months. Revisions not received within two months from the date of notice will have its process canceled. All revisions must be accompanied with a letter detailing the changes made to the original document; changes should also be indicated directly on the manuscript. Papers must have their copyright assigned to the BJPS before being submitting to the Journal.
Chemical Abstracts - Coden CHABAB.
• Literatura Latino-Americana e do Caribe em Ciências da Saúde - Lilacs
• QUALIS/CAPES- Classificação B3 para Farmácia. Website: www.periodicos.capes.gov.br
The publication receives finnancial support from:
- Programa de Apoio às Publicações Científicas Periódicas da USP.
- CNPq – Conselho Nacional de Desenvolvimento Científica e Tecnológico
Sources of Support
The Brazilian Journal of Pharmaceutical Sciences has its origin in the "Anais de Farmácia e Odontologia da USP", which began in 1939. In 1963, volume 1 of "Revista da Faculdade de Farmácia e Bioquímica da Universidade de São Paulo" was published and in 1970, it was changed to "Revista de Farmácia e Bioquímica da Universidade de São Paulo". In 1999, it was totally remodeled and named as Revista Brasileira de Ciências Farmacêuticas/Brazilian Journal of Pharmaceutical Sciences. From 2009 on, after 10 years of its first editorial reformulation and celebrating 70 years of publishing, a new phase has started, and the publication is now Brazilian Journal of Pharmaceutical Sciences, accepting papers only in English. This decision has the main purpose of widening its visibility outside the country, towards consolidating its role as the main publication in the Pharmaceutical Sciences area in Brazil.